[
  {
    "ts": null,
    "headline": "Incyte Corp. stock outperforms competitors despite losses on the day",
    "summary": "Incyte Corp. stock outperforms competitors despite losses on the day",
    "url": "https://finnhub.io/api/news?id=48cb8d14c760856be27ab165a4f97d4a7862c71901d47fe2a0bff6cb4de1a2dd",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731518040,
      "headline": "Incyte Corp. stock outperforms competitors despite losses on the day",
      "id": 131432730,
      "image": "",
      "related": "INCY",
      "source": "MarketWatch",
      "summary": "Incyte Corp. stock outperforms competitors despite losses on the day",
      "url": "https://finnhub.io/api/news?id=48cb8d14c760856be27ab165a4f97d4a7862c71901d47fe2a0bff6cb4de1a2dd"
    }
  },
  {
    "ts": null,
    "headline": "Analysis Group - Reports by Managing Principal John Jarosz Cited in Grant of Preliminary Injunction in Patent Infringement Case",
    "summary": "Analysis Group was retained to work with Incyte Corporation, the plaintiff in a patent infringement case against Sun Pharmaceutical Industries.Incyte, maker of Jakafi, approved for certain oncology...",
    "url": "https://finnhub.io/api/news?id=d737936e0617cb4f6292678de0bc9394063e9ffde218dbd544293d3bc767fa4e",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731493055,
      "headline": "Analysis Group - Reports by Managing Principal John Jarosz Cited in Grant of Preliminary Injunction in Patent Infringement Case",
      "id": 131325231,
      "image": "",
      "related": "INCY",
      "source": "Finnhub",
      "summary": "Analysis Group was retained to work with Incyte Corporation, the plaintiff in a patent infringement case against Sun Pharmaceutical Industries.Incyte, maker of Jakafi, approved for certain oncology...",
      "url": "https://finnhub.io/api/news?id=d737936e0617cb4f6292678de0bc9394063e9ffde218dbd544293d3bc767fa4e"
    }
  }
]